Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
Nohela B. Arévalo, Cristian M. Lamaizon, Viviana A. Cavieres, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 17

Showing 17 citing articles:

A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy
Alan B. Moy, Anant Kamath, Sara Ternes, et al.
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 11
Lipid accumulation drives cellular senescence in dopaminergic neurons
Taylor Russo, Markus Rießland
Aging (2024)
Open Access | Times Cited: 4
Organellar crosstalk as a potential therapeutic target for rare neurodegenerative diseases
Josephine Lam, Chenxu Li, Márcia R. Terluk, et al.
Rare Disease and Orphan Drugs Journal (2025) Vol. 4, Iss. 1
Open Access
AAV-mediated GBA1 and GDNF rescue neurological defects in a murine model of neuronopathic Gaucher disease
Yuan Meng, Jiale Zhang, Ruifeng Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102506-102506
Open Access
Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
Andrés D. Klein, Tiago F. Outeiro
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Neuronopathic Gaucher disease: Rare in the West, common in the East
Özlem Göker-Alpan, Margarita M. Ivanova
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 5, pp. 917-934
Open Access | Times Cited: 3
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
Margarita M. Ivanova, Julia Dao, Neil Kasaci, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
Does glial lipid dysregulation alter sleep in Alzheimer’s and Parkinson’s disease?
Lindsey D. Goodman, Matthew J. Moulton, Guang Lin, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 913-923
Closed Access | Times Cited: 1
Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome
Holly Monkhouse, Janet E. Deane
Biochemical Society Transactions (2024)
Open Access | Times Cited: 1
The molecular mechanism of Gaucher disease caused by compound heterozygous mutations in GBA1 gene
Qi Liu, Zongrui Shen, Hong Pan, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 2
Gaucher’s Disease – current state of knowledge and future perspectives?
Katarzyna Szymańska, Julia Krasnoborska, Sylwia Samojedny, et al.
Journal of Education Health and Sport (2024) Vol. 64, pp. 131-148
Open Access
Targeting N-Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors
Janja Sluga, Tihomir Tomašič, Marko Anderluh, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 751-751
Open Access
Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease
Asuka Hamamoto, Natsuki Kita, Siddabasave Gowda B. Gowda, et al.
Cell Structure and Function (2023) Vol. 49, Iss. 1, pp. 1-10
Open Access | Times Cited: 1
Multiplex Quantification of Plasma Biomarkers for Patients with Gaucher Disease Type 1
Iskren Menkovic, Michel Boutin, Paméla Lavoie, et al.
Current Protocols (2023) Vol. 3, Iss. 2
Open Access
Page 1

Scroll to top